(Press-News.org) The risks and benefits of red blood cell transfusions for patients with trauma and major bleeding might vary considerably based on a patient's predicted risk of death on arrival at a trauma centre, according to new research published in this week's PLOS Medicine. The study by Pablo Perel, from the London School of Hygiene & Tropical Medicine, United Kingdom, and colleagues, suggests that trauma patients who have the highest predicted risk of death on arrival at a trauma centre receive the greatest benefit from red blood cell transfusions but for those with the lowest predicted risk of death at baseline red blood cell transfusion is associated with a higher chance of death.
The authors of the study used data from the CRASH-2 trial that evaluated the effect of tranexamic acid (which reduces blood loss) in patients with trauma, which included 20,127 trauma patients with significant bleeding from 274 hospitals in 40 countries. The authors evaluated the association between receiving red blood cell transfusion versus not receiving a red blood cell transfusion with deaths by all causes at 28 days post trauma. The findings were stratified by predicted risk of death based on clinical observations on arrival at the trauma centre.
The authors found that those at greatest predicted risk of dying (>50%) had a smaller chance of death from all causes if they were transfused (an odds ratio (OR) of 0.59 (95% confidence interval [CI] 0.47–0.74)), while for those in the 21%–50% risk group there was no significant difference in their chance of dying based on whether they are transfused or not (OR 0.92, 95% CI 0.78–1.08). However, for those within the lower risk strata, transfusion was associated not with benefit but with harm. Patients at a 6%–20% chance of death had an OR of 2.31 (95% CI 1.96–2.73) for dying if they received a transfusion, while for those whose initial risk was below 6%, the OR for death associated with transfusion was 5.40 (95% CI 4.08– 7.13). In absolute figures, compared to no transfusion, RBC transfusion was associated with 5.1 (95% CI 4.3 to 6.0) more deaths per 100 patients in the patient group with the lowest predicted risk of death but with 11.9 (95% CI 7.1 to 16.7) fewer deaths per 100 patients in the group with the highest predicted risk of death.
The authors caution, "[o]ur study suggests that blood transfusion could be harmful for those patients whose predicted risk of death is low. However, as our study was observational, important biases cannot be ruled out, and we cannot claim a causal link. Therefore, this hypothesis should be prospectively evaluated in a randomised controlled trial."
In an accompanying Perspective article PLOS Medicine Consulting Editor Druin Burch notes, "[w]ith so many dying each year, and with deaths from injury set to rise in importance as road traffic crashes and violent injuries account for a greater portion of the global burden of disease, we have a compelling reason to improve and rationalize our transfusion strategies."
INFORMATION:
Research Article
Funding: This study was supported by PROGRESS Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership [G0902393/99558]. DA, PC and IR are UK NIHR Senior Investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Perel P, Clayton T, Altman DG, Croft P, Douglas I, et al. (2014) Red Blood Cell Transfusion and Mortality in Trauma Patients: Risk-Stratified Analysis of an Observational Study. PLoS Med 11(6): e1001664. doi:10.1371/journal.pmed.1001664
Author Affiliations:
London School of Hygiene & Tropical Medicine, UK
University of Oxford, UK
Keele University, UK
University College London, UK
The University of Melbourne, Australia
University of Birmingham, UK
London Chest Hospital
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001664
Contact:
Pablo Perel
London School of Hygiene & Tropical Medicine
UNITED KINGDOM
pablo.perel@lshtm.ac.uk
Perspective Article
Funding: Druin Burch is a Consulting Editor for PLOS Medicine and is paid by the Public Library of Science on a freelance basis.
Competing Interests: DB has helped with recruitment to the HALT-IT trial of tranexamic acid in upper gastrointestinal haemorrhages on behalf of the general medical service at the Oxford University Hospitals NHS Trust. The trial is not directly related to the CRASH-2 study but is coordinated by the same research unit. DB received no financial reward for his involvement in the HALT-IT trial.
Citation: Burch D (2014) Blood Transfusions following Trauma: Finding an Evidence-Based Vein. PLoS Med 11(6): e1001665. doi:10.1371/journal.pmed.1001665
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001665
Contact:
PLOS Medicine
plosmedicine@plos.org
Transfusion after trauma can benefit or harm patients depending on their risk of death
2014-06-18
ELSE PRESS RELEASES FROM THIS DATE:
Moving toward improved cell replacement therapy for Parkinson's disease
2014-06-18
Parkinson's disease, which affects millions worldwide, results from neuron loss. Transplantation of fetal tissue to restore this loss has shown promise, but ethical concerns over acquiring this tissue limit its use.
In a June 17 study in the Journal of Clinical Investigation, Vania Broccoli and others at the San Raffaele Scientific Institute converted fibroblasts into neurons and engrafted them into the brains of rodents with parkinsonism. The cells improved motor function, but not as well as transplanted rat fetal tissues. The authors then used a technology that allows ...
Role reversal: Linking a reproductive pathway to obesity
2014-06-18
People and mice with mutations in a specific signaling pathway, known as kisspeptin, suffer reproductive effects such as delayed puberty and infertility. Research of this pathway has focused on its role in reproduction, but a June 17 study in the Journal of Clinical Investigation looked at its effects on metabolism.
Alexander Kauffman and colleagues at the University of California San Diego found that lack of the kisspeptin pathway in female mice promotes excess weight gain. Mice became overweight as the result of a reduced metabolism and decreased energy, but not as ...
A new twist on neuro disease: Discovery could aid people with dystonia, Parkinson's and more
2014-06-18
ANN ARBOR, Mich. -- Twist and hold your neck to the left. Now down, and over to the right, until it hurts. Now imagine your neck – or arms or legs – randomly doing that on their own, without you controlling it.
That's a taste of what children and adults with a neurological condition called dystonia live with every day – uncontrollable twisting and stiffening of neck and limb muscles.
The mystery of why this happens, and what can prevent or treat it, has long puzzled doctors, who have struggled to help their suffering dystonia patients. Now, new re-search from a University ...
Stress hormone linked to short-term memory loss as we age
2014-06-18
A new study at the University of Iowa reports a potential link between stress hormones and short-term memory loss in older adults.
The study, published in the Journal of Neuroscience, reveals that having high levels of cortisol—a natural hormone in our body whose levels surge when we are stressed—can lead to memory lapses as we age.
Short-term increases in cortisol are critical for survival. They promote coping and help us respond to life's challenges by making us more alert and able to think on our feet. But abnormally high or prolonged spikes in cortisol—like what ...
Kidney problems may prevent heart attack patients from receiving life-saving care
2014-06-18
Heart attack patients with kidney problems may not be getting the full treatment they need, according to a new study led by King's College London. The study found that patients admitted to hospital with chest pains and poorly functioning kidneys are less likely to be given an angiogram and early invasive treatment, which might increase their chance of surviving a heart attack.
People admitted to hospital with a suspected heart attack are normally offered early angiography or X-ray of their heart – a procedure recommended in UK, European and US healthcare guidelines regardless ...
What amino acids in shells can tell us about Bronze Age people
2014-06-18
A new study by scientists at the University of York has shed new light on the use of mollusc shells as personal adornments by Bronze Age people.
The research team used amino acid racemisation analysis (a technique used previously mainly for dating artefacts), light microscopy, scanning electron microscopy and Raman spectroscopy, to identify the raw materials used to make beads in a complex necklace discovered at an Early Bronze Age burial site at Great Cornard in Suffolk, UK.
They discovered that Bronze Age craftspeople used species like dog whelk and tusk shells, both ...
Brain imaging shows enhanced executive brain function in people with musical training
2014-06-18
BOSTON (June 17, 2014)—A controlled study using functional MRI brain imaging reveals a possible biological link between early musical training and improved executive functioning in both children and adults, report researchers at Boston Children's Hospital. The study, appearing online June 17 in the journal PLOS ONE, uses functional MRI of brain areas associated with executive function, adjusting for socioeconomic factors.
Executive functions are the high-level cognitive processes that enable people to quickly process and retain information, regulate their behaviors, make ...
Stress hormone elevation is associated with working memory deficits in aging
2014-06-18
Washington, DC — A new study published in the June 18 issue of The Journal of Neuroscience adds to a body of evidence suggesting stress may accelerate cognitive decline later in life. The study found that aged rats with high levels of the stress hormone corticosterone showed structural changes in the brain and short-term memory deficits.
While most people will experience some cognitive decline as they get older, the extent of these changes and how rapidly they progress varies greatly from one person to the next. Scientists are interested in understanding the factors ...
Penn Medicine study shows 'clot-busting' drugs reduce deaths from pulmonary embolism by nearly half
2014-06-17
PHILADELPHIA - Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant medications alone. A pulmonary embolism is a blockage of one or more arteries in the lungs, primarily because of blood clots that travel there ...
Analysis finds mixed results for use of thrombolytic therapy for blood clot in lungs
2014-06-17
In an analysis that included data from 16 trials performed over the last 45 years, among patients with pulmonary embolism, receipt of therapy to dissolve the blood clot (thrombolysis) was associated with lower rates of death, but increased risks of major bleeding and intracranial hemorrhage, according to a study in the June 18 issue of JAMA. The authors note that these findings may not apply to patients with low-risk pulmonary embolism.
Pulmonary embolism (PE; a blockage of the main artery of the lung or one of its branches) is an important cause of illness and death, ...